EIF2AK2 and Alzheimer disease: Given that significant elevations in total PKR and p-PKR concentrations have been documented in AD and amnestic mild cognitive impairment subjects, the assessment of T-PKR and p-PKR in cerebrospinal fluid could be used to diagnose AD (Mouton-Liger et al., 2012).